pharma · Diphtheria · Diabetes Mellitus, Type 2
Sanofi Pasteur MSD
Sanofi Pasteur
Sanofi Pasteur is a pharma organization headquartered in LYON, FR. Primary therapeutic focus areas include Diphtheria, Diabetes Mellitus, Type 2, Japanese Encephalitis, Rabies, Hemophilia A. NovaPharmaNews links 83 clini
France, LYON HQ
363 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- France, LYON
- Employees
- 363
- Programs
- 83
- Drugs
- 66
- Patents
- 0
ChimeriVax-JE, Japanese Encephalitis vaccine
Phase 3 · mab · Encephalitis
ChimeriVax-JE, Japanese Encephalitis vaccine for Encephalitis is a Phase 3 program (mab) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).
Internal code H-040-010
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Sanofi Pasteur
- Phase
- Phase 3
- Modality
- mab
- Indication
- Encephalitis
- Status
- completed
- Trials
- 1